使用类克治疗克罗恩病的效果观察及护理

Observation and Nursing of the Effect of Treating Crohn’s Disease with Remicade

目的探讨使用类克治疗克罗恩病的临床效果以及护理措施。方法方便选取该院2015年10月—2017年10月在该院接受治疗的50例克罗恩病患者作为研究对象,采用随机数字表法将所有纳入研究的患者分为两组,每组克罗恩病患者有25例,对照组患者采用常规的治疗措施,实验组患者在对照组治疗基础上采用类克进行治疗,两组患者实施优质的护理措施,比较两组患者的临床有效率、输液不良反应发生率和住院时间。结果实验组患者的临床有效率是100.00%,比对照组高86.00%,两组临床观察数据比较差异有统计学意义(χ^2=5.5556,P=0.0184);输液不良反应发生率是4.00%,比对照组低24.00%,两组临床观察数据比较差异有统计学意义(χ^2=4.1528,P=0.0416);住院时间为(3.2±1.9)d,比对照组患者的住院时间(21.7±12.5)d短,两组临床观察数据比较差异有统计学意义(t=7.3160,P=0.0000)。结论对克罗恩病患者采用常规治疗的基础上实施类克的治疗方法可以取得较好的临床疗效,患者的输液不良反应发生率低,住院时间短,值得在临床上应用推广。

Objective To investigate the clinical effects and nursing measures of the treatment of Crohn's disease with remicade treatment. Methods A total of 50 patients with Crohn's disease who were treated in our hospital from October 2015 to October 2017 were convenient enrolled. All patients included in the study were randomly divided into two groups. There were 25 patients with encephalopathy. The patients in the control group were treated with conventional treatment. The patients in the experimental group were treated with remicade treatment on the basis of the control group. The two groups of patients were treated with high quality nursing measures. The clinical effectiveness and infusion of the two groups were compared. The incidence of adverse reactions and hospital stay. Results The clinical effective rate of the experimental group was 100.00%, which was 80.00% higher than that of the control group. The clinical observation data of the two groups were statistically significant(χ^2=5.555 6,P=0.018 4), and the incidence of adverse reactions of infusion was 4.00%. Compared with the control group of 24.00%. The clinical observation data of the two groups were statistically significant(χ^2=4.152 8,P=0.041 6), and the hospitalization time was (3.2±1.9)d. The hospitalization time was (21.7±12.5)d compared with the control group. The days were shorter, and the difference between the two groups was statistically significant(t=7.316 0,P=0.000 0). Conclusion The treatment of patients with Crohn's disease can achieve better clinical results based on the treatment of remicade treatment. The incidence of adverse reactions of infusion is low and the hospitalization time is short. It is worthy of clinical application.